Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Clinical Trial

Research Support, Non-U.S. Gov't

Comparative Study

Multicenter Study

Research Support, N.I.H., Extramural

Clinical Trial, Phase III

Review

Publication Year

From

Quick links

Individual year

2016

2015

2014

2008

2007

2006

2005

2004

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Gatifloxacin""[mesh_terms]

20 Results

Searching titles within these results

Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.

Sanjay K Motwani, Shruti Chopra, Sushma Talegaonkar, Kanchan Kohli, Farhan J Ahmad, Roop K Khar

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2008;68(3):513-25

Full Text

Abstract

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.

A P Mazurek, J Biernacka, K Betlejewska-Kielak, M Grudzień, F A Pluciński, E Kłosińska-Szmurło

Journal of biological physics 2015;40(4):335-45

Free Full Text

Abstract

Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers.

Michael B Kays, Brian R Overholser, Seema Lagvankar, Mitchell Goldman, Kevin M Sowinski

Pharmacotherapy 2006;25(11):1530-5

Full Text

Abstract

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

J L Johnson, D J Hadad, W H Boom, C L Daley, C A Peloquin, K D Eisenach, D D Jankus, S M Debanne, E D Charlebois, E Maciel, M Palaci, R Dietze

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(6):605-12

Full Text

Abstract

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

D A Gajjar, F P LaCreta, G D Kollia, R R Stolz, S Berger, W B Smith, M Swingle, D M Grasela

Pharmacotherapy 2000;20(6 Pt 2):76S-86S

Full Text

Abstract

Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.

Paul M Ridker, Christopher P Cannon, Eugene Braunwald, David A Morrow, Jessica L Mega, Sabina Murphy, Richard Cairns

Journal of thrombosis and thrombolysis 2006;22(1):71-6

Full Text

Abstract

A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.

Lawrence D Sher, Michael A McAdoo, Robert B Bettis, Mark A Turner, Nicole F Li, Phillip F Pierce

Clinical therapeutics 2002;24(2):269-81

Full Text

Abstract

Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.

Amy Shui, Kausik K Ray, David A Morrow, Eugene Braunwald, Christopher P Cannon, Marc S Sabatine, Nader Rifai

Circulation 2007;115(24):3071-8

Full Text

Abstract

Clinical pharmacology of gatifloxacin, a new fluoroquinolone.

D M Grasela

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31 Suppl 2():S51-8

Full Text

Abstract

Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.

Linda Duxfield, Ruokai Wang, Vanessa Englebretsen, Samantha Deo, Rubab Sultana, Simon Swift, Ilva Rupenthal, Raida Al-Kassas

Pharmaceutical development and technology 2016;21(2):172-9

Full Text

Abstract

Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.

Reynaldo Dietze, W Henry Boom, Moises Palaci, Lucilia Pereira Dutra Molino, David Jamil Hadad, Charles A Peloquin, John L Johnson

Antimicrobial agents and chemotherapy 2008;52(3):852-7

Free Full Text

Abstract

Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.

Xavier Sáez-Llorens, Adriano Arguedas, Kamal A Hamed, Joanna Yang, Phillip Pierce, Roger Echols, Adib Rodriguez

The Pediatric infectious disease journal 2005;24(4):293-300

Full Text

Abstract

Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.

M Solèr, H Lode, R Baldwin, J H A Levine, A J M Schreurs, J A van Noord, F P V Maesen, M Zehrer

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2003;22(3):144-50

Full Text

Abstract

Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.

H Lode, P Magyar, J F Muir, U Loos, K Kleutgens

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):512-20

Free Full Text

Abstract

Notes on testing noninferiority in ordinal data under the parallel groups design.

Kuang-Chao Chang, Kung-Jong Lui

Journal of biopharmaceutical statistics 2014;23(6):1294-307

Full Text

Abstract

Results: 1 – 15 / 20

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Gatifloxacin""[mesh_terms]

Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.

Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability.

Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers.

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.

A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.

Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.

Clinical pharmacology of gatifloxacin, a new fluoroquinolone.

Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.

Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis.

Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.

Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.

Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.

Notes on testing noninferiority in ordinal data under the parallel groups design.

Results for
""Gatifloxacin""[mesh_terms]